Table 2.
Outcomes on primary and secondary measures
| Pre | Post | 2-Month follow-up | 6-Month follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M (SD) | M (SD) | Est. mean change (SE) | d’ | M (SD) | Est. mean change (SE) | d′ | M (SD) | Est. mean change (SE) | d′ | |
| CAPS-5 | 49.5 (9.2) | 31.8 (14.1) | 17.7 (1.9) | 1.4 | 27.1 (17.8) | 22.4 (2.5) | 1.3 | 26.2 (18.4) | 23.4 (2.4) | 1.4 |
| PDSS | 9.9 (5.4) | 7.5 (6.4) | 2.4 (0.9) | 0.4 | 6.0 (6.4) | 3.9 (1.0) | 0.6 | 5.2 (7.3) | 4.7 (1.1) | 0.7 |
| CHRT-SR | 15.4 (8.8) | 11.3 (9.7) | 4.2 (1.2) | 0.5 | 11.0 (10.1) | 4.5 (1.3) | 0.5 | 10.4 (9.3) | 5.0 (1.4) | 0.5 |
| PHQ-9 | 14.7 (4.9) | 10.8 (7.1) | 4.0 (0.9) | 0.6 | 11.8 (6.9) | 2.9 (1.0) | 0.4 | 10.2 (6.5) | 4.5 (1.0) | 0.6 |
| CGI-S | 4.8 (0.6) | 3.2 (1.3) | 1.6 (0.2) | 1.2 | 3.0 (1.6) | 1.9 (0.2) | 1.2 | 3.0 (1.8) | 1.8 (0.3) | 1.0 |
| SF-363 | 13.2 (27.3) | 37.5 (40.5) | 24.3 (5.7) | 0.6 | 37.1 (43.0) | 23.9 (6.6) | 0.5 | 43.9 (39.6) | 30.7 (6.1) | 0.7 |
| ETCO2 | 36.2 (4.3) | 37.9 (4.3) | 1.7 (0.7) | 0.3 | ||||||
| RR | 14.9 (3.9) | 12.8 (6.3) | 2.1 (0.7) | 0.4 | ||||||